Industry committee  Maybe I'll answer that, and perhaps my colleague can expand on my answer. The regulations that were referred to by Mr. Janigan were pursuant to section 24 of the Competition Act. That section gives the Governor in Council the ability to make regulations with respect to sections

Industry committee  It would be up to the Commissioner of Competition to determine whether she had sufficient grounds or not.

Industry committee  She'd have to look back at case law and some other statutes. Maybe you could expand a bit on that, Rhona.

Bill C-32 (40th Parliament, 3rd Session) committee  I do have a long list of the many things we did hear from stakeholders that were addressed in the bill. I'm having difficulty finding that in my notes right now, for some reason. I apologize for that. Here it is. The first thing is that we did hold consultations, as you said, an

Bill C-32 (40th Parliament, 3rd Session) committee  Thank you for the question. A number of provisions in Bill C-32 deal with the things you're mentioning. Some of the key provisions include provisions that promote computer program innovation, allowing third-party software companies to do things like engage in the development of

Industry committee  Right. I guess the way we would think about the issue is that the regime in CAMR is not enforced by the government; it's meant to be enforced by rights holders. So the transparency requirements--for example, some of the things that are dealt with in section 21.16 of the Patent Ac

Industry committee  My understanding is that if clause 9 is defeated--

Industry committee  That's right.

Industry committee  I think we all agree that it's a pretty dry subject area, but it's an important area, because basically the patent system is set up to reward investment, particularly in the area of medicines, where the investment can be huge to develop new medicines and bring them to production.

Industry committee  As it stands without the amendments that are proposed--just as clause 3 stands--or as the amendments are proposed to clause 3 in Bill C-393: is that the question?

Industry committee  This is the one that would have completely removed the process for amending schedule 1 to CAMR, the access to medicines regime. It would collapse schedules 2 to 4, the lists of countries, into one list, without any additional requirements or parameters around those lists. So wh

Industry committee  We're happy to answer that question. The second set of Liberal amendments in our package don't have numbers on them, so it's a bit difficult to follow which is Lib-1.1 and which is Lib-1.2. Is Lib-1.2 the amendment that replaces line 1 on page 2 with some text? Is it subclause

Industry committee  Are you asking if we could comment on the implications of withdrawing clauses 6, 7, 8, 11, 12 and 14? I think that's a very difficult thing to do without stopping and going through the amendments themselves, looking at what that means, and making an assessment of that. We need ti

Industry committee  It still would leave some problematic clauses in place, in the government's view, particularly clause 4, which you've heard has some pretty significant implications. If it were to remain in place, then we would obviously have concerns about that, as you've heard.

Industry committee  This change would not impact that second health approval process that is eliminated in CAMR.